JP2013523783A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523783A5 JP2013523783A5 JP2013502959A JP2013502959A JP2013523783A5 JP 2013523783 A5 JP2013523783 A5 JP 2013523783A5 JP 2013502959 A JP2013502959 A JP 2013502959A JP 2013502959 A JP2013502959 A JP 2013502959A JP 2013523783 A5 JP2013523783 A5 JP 2013523783A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- fragment
- env
- protein
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32239910P | 2010-04-09 | 2010-04-09 | |
| US61/322,399 | 2010-04-09 | ||
| PCT/AU2011/000407 WO2011123900A1 (en) | 2010-04-09 | 2011-04-11 | Methods and compositions for inhibiting hiv transmission |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523783A JP2013523783A (ja) | 2013-06-17 |
| JP2013523783A5 true JP2013523783A5 (https=) | 2014-05-29 |
| JP6026402B2 JP6026402B2 (ja) | 2016-11-16 |
Family
ID=44761932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013502959A Expired - Fee Related JP6026402B2 (ja) | 2010-04-09 | 2011-04-11 | Ｈｉｖの伝染を抑制する方法及び組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130022619A1 (https=) |
| EP (1) | EP2555798B1 (https=) |
| JP (1) | JP6026402B2 (https=) |
| CN (1) | CN103167881B (https=) |
| AP (1) | AP3469A (https=) |
| AU (2) | AU2011238431B2 (https=) |
| BR (1) | BR112012025678A2 (https=) |
| CA (1) | CA2795853A1 (https=) |
| MX (1) | MX343505B (https=) |
| RU (1) | RU2594249C2 (https=) |
| WO (1) | WO2011123900A1 (https=) |
| ZA (1) | ZA201207790B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2925471A1 (en) | 2013-09-27 | 2015-04-02 | Duke University | Hiv-1 mother-to-child transmission correlates of protection and vaccine |
| CN103736100B (zh) * | 2013-12-25 | 2017-06-09 | 南方医科大学 | 预防hiv性传播的杀微生物剂酸酐修饰抗sevi多克隆抗体 |
| AU2016326738B2 (en) * | 2015-09-24 | 2023-08-31 | Abvitro Llc | HIV antibody compositions and methods of use |
| WO2017062069A1 (en) * | 2015-10-07 | 2017-04-13 | Eca Medical Instruments | Gearless spring torque drive |
| US10973679B2 (en) * | 2016-02-12 | 2021-04-13 | Adam Arreola | STD detecting condom |
| AU2021289612A1 (en) * | 2020-06-10 | 2023-01-19 | The University Of Melbourne | HIV-1 antibodies |
| US20240262893A1 (en) | 2021-05-12 | 2024-08-08 | Applied Biomedical Science Institute | Binding polypeptides against sars cov-2 and uses thereof |
| WO2022241058A1 (en) | 2021-05-12 | 2022-11-17 | Applied Biomedical Science Institute | Methods of screening and expression of disulfide-bonded binding polypeptides |
| JP7421610B1 (ja) | 2022-08-18 | 2024-01-24 | 株式会社マーベラス | ゲーム装置 |
| EP4619430A1 (en) | 2022-11-16 | 2025-09-24 | Applied Biomedical Science Institute | Fusion polypeptides and binding peptides and methods for producing and using same |
| WO2026073047A1 (en) | 2024-09-27 | 2026-04-02 | Applied Biomedical Science Institute | Methods of screening and expressing cis-display libraries of disulfide-rich polypeptides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6039957A (en) * | 1993-12-10 | 2000-03-21 | United States Of America, As Represented By The Department Of Health And Human Services | Oligomeric HIV-1 envelope glycoproteins |
| CN101912610A (zh) * | 1999-06-24 | 2010-12-15 | 约翰·霍普金斯大学 | 用于预防hiv经上皮传播的组合物和方法 |
| ATE350015T1 (de) * | 2000-09-28 | 2007-01-15 | Novartis Vaccines & Diagnostic | Mikropartikelzusammensetzungen und verfahren zu ihrer herstellung |
| WO2008063331A2 (en) * | 2006-10-23 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof |
| CA2704059A1 (en) * | 2007-10-30 | 2009-05-07 | International Aids Vaccine Initiative | Antigen-antibody complexes as hiv-1 vaccines |
| CA2739905A1 (en) * | 2008-10-30 | 2010-08-26 | Dana-Farber Cancer Institute | Mimotopes of hiv env |
-
2011
- 2011-04-11 MX MX2012011574A patent/MX343505B/es active IP Right Grant
- 2011-04-11 CN CN201180028300.5A patent/CN103167881B/zh not_active Expired - Fee Related
- 2011-04-11 AP AP2012006519A patent/AP3469A/xx active
- 2011-04-11 BR BR112012025678A patent/BR112012025678A2/pt not_active Application Discontinuation
- 2011-04-11 WO PCT/AU2011/000407 patent/WO2011123900A1/en not_active Ceased
- 2011-04-11 CA CA2795853A patent/CA2795853A1/en not_active Abandoned
- 2011-04-11 AU AU2011238431A patent/AU2011238431B2/en not_active Ceased
- 2011-04-11 JP JP2013502959A patent/JP6026402B2/ja not_active Expired - Fee Related
- 2011-04-11 US US13/639,831 patent/US20130022619A1/en not_active Abandoned
- 2011-04-11 EP EP11764957.4A patent/EP2555798B1/en not_active Not-in-force
- 2011-04-11 RU RU2012142999/15A patent/RU2594249C2/ru not_active IP Right Cessation
-
2012
- 2012-10-17 ZA ZA2012/07790A patent/ZA201207790B/en unknown
-
2017
- 2017-11-22 AU AU2017265055A patent/AU2017265055A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523783A5 (https=) | ||
| JP2017035093A5 (https=) | ||
| WO2017123636A8 (en) | Dosage and administration of anti-c5 antibodies for treatment | |
| CY1123462T1 (el) | Αντισωματα που εξουδετερωνουν ισχυρα τον ιο ηπατιτιδας β και χρησεις αυτων | |
| CY1124618T1 (el) | Ανασυνδυασμενοι hvt φορεις οι οποιοι εκφραζουν αντιγονα παθογονων των πτηνων και χρησεις αυτων | |
| JP2018064580A5 (https=) | ||
| EP3266464A3 (en) | Yeast-based therapeutic for chronic hepatitis b infection | |
| EP2601969A3 (en) | Norovirus vaccine formulations | |
| JP2017507117A5 (https=) | ||
| WO2012006596A3 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| Lai et al. | A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1 | |
| JP2010521147A5 (https=) | ||
| HK1254950A1 (zh) | 中和人体呼吸道合胞体病毒的抗体 | |
| WO2007081447A3 (en) | Norovirus and sapovirus antigens | |
| JP2017524339A5 (https=) | ||
| WO2014018858A3 (en) | Multimeric fusion protein vaccine and immunotherapeutic | |
| EP4292659A3 (en) | Antibodies that neutralize hepatitis b virus and uses thereof | |
| WO2013063366A3 (en) | Methods for screening viral like particles and identifying neutralizing epitopes and related vaccines, constructs, and libraries | |
| JP2013539454A5 (https=) | ||
| JP2015524422A5 (https=) | ||
| WO2011094357A3 (en) | Repiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization | |
| JP2017526689A5 (https=) | ||
| WO2006041933A3 (en) | Improved vaccines | |
| EA200900033A1 (ru) | Вакцины против малярии |